Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. (CLDI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLDI · as of Jun 8, 2026
Key Statistics
Explore Calidi Biotherapeutics, Inc. Data
cldi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The CLDI analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +3105.13% upside from the current price of $0.17.
Competitors & Peers
cldi competitorsCLDI
CANF
CMND
CNSP
KZIA
QLGNStock Performance
Full HistoryAbout Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable…
what is calidi biotherapeutics, inc. · cldi stock overview · calidi biotherapeutics, inc. company profile · who is calidi biotherapeutics, inc. ceo · cldi AMEX · calidi biotherapeutics, inc. headquarters · calidi biotherapeutics, inc. business segments
About Stock Overview & Key Data
Calidi Biotherapeutics, Inc. (CLDI) is a Healthcare company in the Biotechnology industry, listed on AMEX since Nov 1, 2021. As of the latest trading session, CLDI stock price is $0.17, with a market capitalization of $1.3M. The stock has returned -95.61% over the past 12 months and -85.21% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Calidi Biotherapeutics, Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Calidi Biotherapeutics, Inc. reported revenue of — and net income of -$19.9M. For detailed data — including Calidi Biotherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Calidi Biotherapeutics, Inc. (CLDI) stock price is $0.17. The stock is traded on AMEX under the ticker symbol CLDI. The 52-week range is $0.16 – $19.20.